Loading...
XPAR
ERF
Market cap12bUSD
Dec 04, Last price  
58.96EUR
1D
0.65%
1Q
-7.64%
Jan 2017
-85.44%
Name

Eurofins Scientific SE

Chart & Performance

D1W1MN
XPAR:ERF chart
P/E
25.81
P/S
1.51
EPS
2.28
Div Yield, %
0.85%
Shrs. gr., 5y
0.90%
Rev. gr., 5y
8.78%
Revenues
6.95b
+6.70%
233,107,000367,990,000491,773,000632,759,000640,073,000680,333,000828,934,0001,043,963,0001,225,572,0001,410,227,0001,950,074,0002,536,608,0002,971,417,0003,781,148,0004,562,800,0005,438,800,0006,717,700,0006,712,100,0006,514,600,0006,951,000,000
Net income
406m
+30.97%
12,393,00017,508,00017,638,00017,710,000-11,285,00023,400,00055,407,00065,924,00072,180,00079,104,00087,316,000173,997,000216,771,000223,900,000195,200,000539,400,000782,600,000610,200,000310,300,000406,400,000
CFO
1.32b
+29.57%
25,488,00030,178,00039,569,00060,036,00064,337,00084,937,000110,321,000134,161,000169,338,000212,173,000291,146,000371,843,000405,122,000543,895,000677,900,0001,223,500,0001,509,800,0001,136,300,0001,017,900,0001,318,900,000
Dividend
Jul 03, 20240.5 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of approximately 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agro-science, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, and healthcare and cosmetics; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include product compliance and audit, testing, certifications and approvals, inspections, training courses, and digital media and cyber security for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, authenticity, carbohydrates, consulting, dioxins and POPs, food irradiation, labelling, law, heavy metals, identity preservation, mealtime, molecular and microbiology, mycotoxins, nutritional analyses, organic containments, packaging/migration, radioactivity, rapidest, sensorsy and consumer research, trainings, veterinary drug residues, and vitamins services. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and technologies services. It operates approximately 900 laboratories in 54 countries. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
IPO date
Oct 24, 1997
Employees
62,000
Domiciled in
LU
Incorporated in
LU

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT